when will tirzepatide be available in canada GLP-1 medications like Ozempic, Wegovy and Mounjaro are changing diabetes and weight management, but they aren't recommended during pregnancy or while nursing. The current recommendation is to stop before conception and discuss Health Canada Approves Zepbound for

Clinical trials have shown average body weight reductions of 15 to 20 percent over 72 weeks, highlighting its potential impact for those struggling with obesity

277, R742R747

Wrap ice or a cold pack in a thin cloth to prevent direct skin contact and apply for 10-15 minutes

This means insulin release occurs primarily when blood glucose levels are elevated, reducing the risk of hypoglycemia compared to some other diabetes medications

Results: Several studies have discussed the CV beneficial effects of GLP-1 RAs in terms of reducing blood pressure, lipid levels, body weight, risk for arrhythmias, reducing the risk of major adverse CV events, and hospital admission for heart failure